Guardian Research Network

What Guardian Research Network does

Guardian Research Network (GRN) is a 501(c)(3) nonprofit healthcare consortium founded in 2014 and headquartered in Spartanburg, South Carolina. GRN operates a nationwide network of community health systems that aggregate Electronic Medical Record (EMR) data for clinical research and precision medicine purposes. The consortium spans more than 32 U.S. states and encompasses over 40 million patients, 5 million+ oncology patients, 44,000+ network physicians, and 420 million+ clinical notes processed through its NLP pipeline. GRN serves two principal customer groups: community-based health systems that join as consortium members to access clinical trials, precision medicine, and new revenue streams, and life sciences companies (pharmaceutical, biotech, and diagnostic firms) that engage GRN for real-world data analytics, patient matching, virtual comparator cohorts, and clinical trial site activation.

GRN's technology platform centers on proprietary AI, machine learning, and natural language processing (NLP) developed since 2018 that extracts structured and unstructured clinical data from EMR systems. Core products include GRN Fusion (a member-facing data transfer platform that minimizes internal IT burden), the Patient Eligibility Portal (a cloud-based coordinator system for trial matching), an Honest Broker Program for HIPAA-compliant de-identification and re-identification, an IRB-approved BioBank with prospectively consented tissue and genomic data, Virtual Comparator/Synthetic Control technology for FDA-ready external comparator arms, and GRN University for member training launched in 2021. GRN is an Epic development partner with an appliance deployed in Epic's EHR platform since 2020, enabling direct data exchange with member systems.

GRN generates revenue through three streams: subscription-based membership services from health systems, project-based professional services fees from life sciences companies for data analytics, patient matching, and trial support, and managed services revenue from clinical trial site activation and participation fees. The go-to-market motion is direct enterprise engagement on both sides — recruiting health systems as consortium members and life sciences companies as analytics and trial clients. Named life sciences customers include GRAIL (multi-cancer early detection), Oncocyte, Thrive (Exact Sciences), IQVIA, and ThinkGenetic; named health system members include Allina Health, Northeast Georgia Health System, MetroHealth, MUSC, Bozeman Health, Greenwood Genetic Center, and others. The company has achieved SOC 2 Type 2 certification (2022), HIPAA compliance, and ISO 27001 alignment to support protected health information handling at enterprise scale.

Name

Guardian Research Network

Legal name

Guardian Research Network, Inc.

Website

https://guardianresearch.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Guardian Research Network is a nonprofit 501(c)(3) healthcare consortium that aggregates EMR data from community health systems across 32+ states, using proprietary AI/ML/NLP to enable clinical trial matching, real-world data analytics, and precision medicine for life sciences companies and member health systems.

Ownership category

akta.pro rank

Product category

Clinical Research & Real-World Data Analytics

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Voluntary Health Organizations (813212)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Clinical research services
• Real-world data analytics
• Clinical trial matching
• Health data consortium
• Precision medicine research

Headquarters

HQ city

Spartanburg

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Health System Membership Services: GRN provides member health systems with technology, data analytics, and clinical trial matching capabilities. Health systems benefit from new revenue streams, improved patient care, and access to precision medicine trials.
2. Life Sciences Data & Analytics Services: GRN provides pharmaceutical, biotech, and diagnostic companies with real-world data analytics, patient matching, virtual comparator cohorts, and clinical trial support services. Revenue derived from project-based fees for studies, data access, and analytics engagements.
3. Clinical Trial Site Services: GRN enables health system members to offer clinical trials to their patients, generating revenue through trial participation and site activation fees from sponsors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Guardian Research Network operates a nationwide non-profit health system consortium that aggregates Electronic Medical Records from member community health systems and applies proprietary AI/ML/NLP technology to deliver real-world data analytics, clinical trial matching, and precision medicine research support. The organization sells data analytics and patient identification services to life sciences companies and provides technology-enabled research infrastructure to member health systems.

Product overview

Guardian Research Network operates as a unified platform combining real world data analytics with clinical trial matching services. The core platform aggregates data from nationwide health system consortium members and provides trial matching, BioBank tissue services, GRN Fusion data transfer, Patient Eligibility Portal, and Virtual Comparator Cohort capabilities. The system employs proprietary NLP and AI/ML technologies to process structured and unstructured EMR data for precision medicine trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Guardian Research Network Real-World Data Analytics Platform Nationwide health system consortium platform providing real-world data analytics, clinical trial matching, and precision medicine capabilities for life sciences companies and community health systems. Processes structured and unstructured EMR data using proprietary AI/ML/NLP technology.
• GRN Fusion

Quantifiable outcome

• GRN sites enrolled 20% of patients for GRAIL's CCGA research study
• +4 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and strategic.

• Greenwood Genetic CentercoreStrategic or Co-development Partner · 16 October 2024Greenwood Genetic Center joined GRN's nationwide consortium to enhance genetic research nationwide. The collaboration focuses on advancing therapies for rare genetic disorders by combining GGC's 50 years of genetic care and testing data with GRN's national health system network and data analytics capabilities.
• Bozeman HealthcoreStrategic or Co-development Partner · 2 May 2024Bozeman Health became the first Montana member of GRN, expanding research opportunities in Southwest Montana. The partnership focuses on oncology, gastroenterology, and infectious disease research, bringing clinical trials to the community setting.
• Medical University of South Carolina (MUSC)coreStrategic or Co-development Partner · 21 February 2024MUSC became the first academic medical center to join GRN's consortium, augmenting GRN's research capabilities with academic medical center expertise. The partnership contributes to GRN's real-world data pool and brings expanded benchmarking and collaboration opportunities.
• Montrose Regional HealthcoreStrategic or Co-development Partner · 16 November 2023Montrose Regional Health joined GRN's nationwide healthcare research consortium, introducing clinical trial opportunities to Colorado's Uncompahgre Valley. The partnership supports MRH's research by bringing opportunities in multiple care specialties.
• Clemson Rural HealthcoreStrategic or Co-development Partner · 3 October 2023Clemson Rural Health joined GRN to transform health outcomes in rural South Carolina communities through clinical trials. CRH brings a hub-and-spoke model with mobile health units serving a two-hour driving radius.
• MetroHealthcoreStrategic or Co-development Partner · 2 May 2023MetroHealth, serving over 300,000 Ohio patients, joined GRN to expand research and patient care opportunities. The partnership focuses on bringing cancer therapies and clinical trials to underserved communities.
• Allina HealthcoreStrategic or Co-development Partner · 2 February 2023Allina Health, with 12 hospital campuses and 90+ clinics in Minnesota and western Wisconsin, joined GRN to expand precision medicine and translational research capabilities. Partnership focuses on oncology, cardiovascular, and neuroscience research.
• Northeast Georgia Health SystemcoreStrategic or Co-development Partner · 30 September 2022Northeast Georgia Health System, caring for over 1 million people, joined GRN to enhance clinical trial and precision medicine options. NGHS contributes to GRN's real-world healthcare data while gaining access to additional diagnostic and treatment options.
• ThinkGeneticstrategicStrategic or Co-development Partner · 28 July 2022GRN and ThinkGenetic announced a collaborative partnership to accelerate diagnosis and treatment options for patients with genetic diseases and inherited predisposition to cancer, combining technological approaches.
• EpiccoreTechnology or Integration · 1 January 2019GRN became an Epic development partner and deployed an appliance in Epic, enabling direct interface with Epic EHR systems for data exchange and research portal connectivity with member health systems.
• IQVIAstrategicStrategic or Co-development PartnerGRN collaborated with IQVIA to combine oncology data and real-world evidence to advance cancer research. The collaboration guides clinical development decision-making, informs economic evaluations, and supports regulatory submissions.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Tempus Labs: AI-driven precision medicine company that combines multi-modal clinical and molecular data with analytics to support oncology research, clinical trial matching, and drug/diagnostic development — directly comparable to GRN's RWD + AI + clinical trial enablement model.
• Flatiron Health: Oncology-focused real-world data and electronic medical record platform owned by Roche; aggregates de-identified patient data from community oncology practices and partners with life sciences companies for clinical research — the most direct competitor to GRN's oncology RWD offering.
• ConcertAI: Oncology real-world evidence and AI solutions company serving biopharma with patient data, clinical trial solutions, and regulatory-grade analytics — competing with GRN for the same life sciences RWE spend.
• Syapse: Oncology real-world data platform partnering with community health systems and life sciences companies to enable precision medicine and clinical research — a close functional analog to GRN's community-system consortium model.
• OMNY Health: Multi-specialty real-world data network built on de-identified data from community health systems, offering analytics and clinical research services to life sciences — highly comparable to GRN's network-based RWD model.
• Deep 6 AI: AI-powered clinical trial matching platform that mines EHR data to identify eligible patients — overlapping with GRN's Patient Eligibility Portal and AI-driven trial-matching capabilities.
• Cota Healthcare: Oncology real-world data and analytics company providing curated, regulatory-grade datasets and evidence services to life sciences — directly comparable to GRN's oncology analytics study offerings.
• Verana Health: Real-world data company curating specialty clinical data registries (including oncology and ophthalmology) for life sciences research and clinical trial enablement — comparable to GRN's specialty data and analytics approach.

Broad incumbents

• IQVIA: Global clinical research services and real-world evidence giant, already a strategic partner of GRN. Overlaps with GRN's life sciences analytics and trial-services business but operates across all therapeutic areas and geographies with materially broader scope.

Emerging players

• Health Catalyst: Healthcare data and analytics platform serving health systems with population health, quality, and operational analytics; adjacent rather than direct, as Health Catalyst focuses on health-system operations while GRN focuses on clinical research enablement — but both compete for health-system data budgets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC5KrL1QoF_UpUmKLRU3kKig
• LinkedInlinkedin.com/company/guardian-research-network
• Xx.com/The_GRN

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Guardian Research Network